Magenta Therapeutics ^Investors

Magenta Therapeutics is an innovative biotechnology company based in Cambridge, Massachusetts, founded in 2015 The company specializes in developing therapies for patients with serious diseases by utilizing its proprietary technologies to enhance stem cell transplantation Magenta Therapeutics has successfully raised significant investment, totaling approximately $100 million, to advance its research and development efforts The organization is committed to transforming the treatment landscape for patients in need of effective and accessible therapies With a strong focus on scientific excellence and collaboration, Magenta Therapeutics aims to deliver groundbreaking solutions in the field of medicine